Publication | Closed Access
Adefovir dipivoxil sensitizes colon cancer cells to vemurafenib by disrupting the KCTD12-CDK1 interaction
37
Citations
39
References
2019
Year
MedicineColon Cancer CellsKctd12-cdk1 InteractionImmunologyReceptor Tyrosine KinaseImmune Checkpoint InhibitorCancer BiologyAnti-cancer AgentAdefovir DipivoxilPharmacologyCell SignalingTumor Biology
| Year | Citations | |
|---|---|---|
Page 1
Page 1